Willis Towers Watson 주식 (NASDAQ: WTW)

에 대한 최신 뉴스 Willis Towers Watson (NASDAQ:WTW) 주식

Willis Towers Watson

NYSE

In January 2016, Towers Watson and Willis Group merged to form Willis Towers Watson, a global advisory, insurance brokerage, and solutions company. The company operates in two business segments: health, wealth, and career (its consulting operations) and risk and brokering (its brokerage operations). It has about 48,000 employees.

홈디포, 보잉 등 주요 기업들이 글로벌 M&amp;A 활동을 촉진하며 $10억 이상의 거래가 재개

Earnings

Equities

News

Markets

Movers

General

버크셔 해서웨이(NYSE:BRK)의 보험 운영 부회장인 아지트 자인(Ajit Jain)은 사이버 보험이 요즘 매우 세련된 공간이 되었다고 말했다. 지난 몇 년 동안 사이버 보험은 전 세계적으로 최소 100억 달러 규모의 시장이 되었다.지난 토요일 네브래스카주 오마하에서 열린 버크셔 해서웨이의 연례 주주총회에서 자인은 사이버 보험의 수익성도 전체 보험료(프리미엄)의 약 20%로 상당히 높다고 말했다.

버크셔 해서웨이의 아지트 자인은 위험 속에서 사이버 보험에 대해 주의 경고

Willis Towers Watson Public Limited Company - Ordinary Shares

Willis Towers Watson PLC

Westwing Group SE

Willis Towers Watson's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NYSE">WTW</a>) short percent of float has risen 38.46% since its last report. The company recently reported that it has 1.41 million shares sold short, which is 1.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.22 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Willis Towers Watson Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736964018_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Willis Towers Watson has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Willis Towers Watson's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Willis Towers Watson's peer group average for short interest as a percentage of float is 2.98%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

(WTW) - Analyzing Willis Towers Watson's Short Interest

Wells Fargo analyst Elyse Greenspan maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Overweight and lowers the price target from $380 to $345.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Willis Towers Watson, Lowers Price Target to $345

In the latest quarter, 7 analysts provided ratings for Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Willis Towers Watson, revealing an average target of $363.71, a high estimate of $400.00, and a low estimate of $302.00. This current average reflects an increase of 4.73% from the previous average price target of $347.29. 
<img src="https://www.benzinga.com/files/images/story/2025/1736539239_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Willis Towers Watson by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$387.00</td>
<td>$378.00</td>
</tr>
<tr>
<td>C. Gregory Peters</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$400.00</td>
<td>$365.00</td>
</tr>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$380.00</td>
<td>$365.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$378.00</td>
<td>$359.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$302.00</td>
<td>$278.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$359.00</td>
<td>$352.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$340.00</td>
<td>$334.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Willis Towers Watson. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Willis Towers Watson compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Willis Towers Watson's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Willis Towers Watson's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/WTW/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Willis Towers Watson analyst ratings.</a>
<h2>Unveiling the Story Behind Willis Towers Watson</h2>
In January 2016, Towers Watson and Willis Group merged to form Willis Towers Watson, a global advisory, insurance brokerage, and solutions company. The company operates in two business segments: health, wealth, and career (its consulting operations) and risk and brokering (its brokerage operations). It has about 48,000 employees.
<h3>Willis Towers Watson: A Financial Overview</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Over the 3 months period, Willis Towers Watson showcased positive performance, achieving a revenue growth rate of 5.68% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Willis Towers Watson's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -73.18%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Willis Towers Watson's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -19.91%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Willis Towers Watson's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -5.9%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.8.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

7 Analysts Assess Willis Towers Watson: What You Need To Know

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Outperform and raises the price target from $378 to $387.

Keefe, Bruyette & Woods Maintains Outperform on Willis Towers Watson, Raises Price Target to $387

Willis Towers Watson's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NYSE">WTW</a>) short percent of float has fallen 4.41% since its last report. The company recently reported that it has 1.02 million shares sold short, which is 1.3% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.18 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Willis Towers Watson Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735566322_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Willis Towers Watson has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Willis Towers Watson's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Willis Towers Watson's peer group average for short interest as a percentage of float is 3.05%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Willis Towers Watson's Recent Short Interest

U.S. stocks settled mixed on Friday, with S&amp;P 500 and Nasdaq Composite hitting fresh records following the release of better-than-expected November jobs data.
The S&amp;P 500 and Nasdaq recorded gains for the third straight week, gaining 0.96% and 3.34%, respectively. However, the Dow lost 0.6% during the week.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: William Power
<ul>
<li>Analyst Firm: Baird</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Maintained an Outperform rating on Axon Enterprise Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) and raised the price target from $600 to $800 on Dec. 6. This analyst sees more than 16% increase in the stock.</li>
<li>Recent News: On Nov. 7, Axon Enterprise reported better-than-expected third-quarter financial results and issued current-quarter revenue guidance above estimates.</li>
</ul>
Analyst: Doug Anmuth
<ul>
<li>Analyst Firm: JP Morgan</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained an Overweight rating on Chewy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) and raised the price target from $37 to $38 on Dec. 5. This analyst sees around 21% surge in the stock.</li>
<li>Recent News: On Dec. 4, Chewy reported worse-than-expected third-quarter sales results and issued FY24 sales guidance below estimates.</li>
</ul>
Analyst: Andrew Kaplowitz
<ul>
<li>Analyst Firm: Citigroup</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained a Buy rating on Mirion Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MIR#NYSE">MIR</a>) and boosted the price target from $18 to $20 on Dec. 4. This analyst sees around 8% upside in the stock.</li>
<li>Recent News: On Dec. 3, Mirion said it sees 2025 organic revenue growth of 5.5% to 7.5%.</li>
</ul>
Analyst: Rob Owens
<ul>
<li>Analyst Firm: Piper Sandler</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained a Neutral rating on Docusign Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) and increased the price target from $60 to $90 on Dec. 6. This analyst sees around 16% decline in the stock.</li>
<li>Recent News: On Dec. 5, DocuSign reported better-than-expected third-quarter financial results and issued FY25 revenue guidance above estimates.</li>
</ul>
Analyst: Mark Hughes
<ul>
<li>Analyst Firm: Truist Securities</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Reiterated a Buy rating on Willis Towers Watson PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) and raised the price target from $365 to $380 on Dec. 4. This analyst sees around 18% upside in the stock.</li>
<li>Recent News: On Oct. 31, Willis Towers Watson reported better-than-expected third-quarter financial results.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42380712/how-to-earn-500-a-month-from-oracle-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Oracle Stock Ahead Of Q2 Earnings</a></li>
</ul>

Pre-Market Outlook

AXON

CHWY

DOCU

This Analyst With 86% Accuracy Rate Sees Around 21% Upside In Chewy - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

Raymond James analyst C. Gregory Peters upgrades Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) from Outperform to Strong Buy and raises the price target from $365 to $400.

Upgrades

Raymond James Upgrades Willis Towers Watson to Strong Buy, Raises Price Target to $400

Truist Securities analyst Mark Hughes reiterates Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Buy and raises the price target from $365 to $380.

Reiteration

Truist Securities Reiterates Buy on Willis Towers Watson, Raises Price Target to $380

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Stifel raised the price target for Couchbase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) from $20 to $22. Stifel analyst Brad Reback maintained a Buy rating. Couchbase shares closed at $21.12 on Tuesday. <a href="https://www.benzinga.com/quote/BASE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley boosted the price target for Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) from $330 to $405. Morgan Stanley analyst Keith Weiss maintained an Overweight rating. Salesforce shares closed at $331.43 on Tuesday. <a href="https://www.benzinga.com/quote/CRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group boosted Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) price target from $122 to $127. Evercore ISI Group analyst Mark Lipacis maintained an Outperform rating. Marvell Technology shares settled at $95.91 on Tuesday. <a href="https://www.benzinga.com/quote/MRVL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird raised MongoDB, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) price target from $305 to $380. Baird analyst William Power maintained an Outperform rating. MongoDB shares closed at $324.01 on Tuesday. <a href="https://www.benzinga.com/quote/MDB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Northland Capital Markets increased The Honest Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNST#NASDAQ">HNST</a>) price target from $7.5 to $9.5. Northland Capital Markets analyst Owen Rickert maintained an Outperform rating. Honest Company shares closed at $8.01 on Tuesday.  <a href="https://www.benzinga.com/quote/HNST/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keefe, Bruyette &amp; Woods boosted Willis Towers Watson Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) price target from $359 to $378. Keefe, Bruyette &amp; Woods analyst Meyer Shields maintained an Outperform rating on the stock. Willis Towers Watson shares closed at $329.06 on Tuesday. See how other analysts view this stock.</li>
<li>Chardan Capital increased the price target for Senti Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) from $10 to $12. Chardan Capital analyst Geulah Livshits maintained a Buy rating. Senti Biosciences shares settled at $7.14 on Tuesday. <a href="https://www.benzinga.com/quote/SNTI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays cut The J. M. Smucker Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJM#NYSE">SJM</a>) price target from $126 to $123. Barclays analyst Andrew Lazar maintained an Equal-Weight rating. Smucker shares closed at $117.29 on Tuesday. <a href="https://www.benzinga.com/quote/SJM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan increased the price target for Trimble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMB#NASDAQ">TRMB</a>) from $74 to $92. JP Morgan analyst Tami Zakaria upgraded the stock from Neutral to Overweight. Trimble shares closed at $73.95 on Tuesday. <a href="https://www.benzinga.com/quote/TRMB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays raised AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) price target from $24 to $27. Barclays analyst Kannan Venkateshwar maintained an Overweight rating. AT&amp;T shares closed at $23.74 on Monday. <a href="https://www.benzinga.com/quote/T/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying T stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="558" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04082646/image-36-1024x558.png" alt="" class="wp-image-676409" style="width:558px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04082646/image-36-1024x558.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04082646/image-36-300x163.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04082646/image-36-768x419.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04082646/image-36.png 1167w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42293707/jim-cramer-prefers-this-delivery-giant-over-ups">Jim Cramer Prefers FedEx Over This Delivery Giant That &#8216;Screwed Up A Lot Of Holiday Seasons&#8217;</a></li>
</ul>

BASE

HNST

MRVL

SNTI

TRMB

AT&T To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Outperform and raises the price target from $359 to $378.

Keefe, Bruyette & Woods Maintains Outperform on Willis Towers Watson, Raises Price Target to $378

The $1 billion increase is in addition to the approximately $660 million remaining on the current open-ended repurchase authority.

Buybacks

WTW Board Approves Increase To Existing Share Repurchase Authority In The Amount Of $1B

Barclays analyst Alex Scott maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Underweight and raises the price target from $278 to $302.

Barclays Maintains Underweight on Willis Towers Watson, Raises Price Target to $302

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Outperform and raises the price target from $352 to $359.

Keefe, Bruyette & Woods Maintains Outperform on Willis Towers Watson, Raises Price Target to $359

Wells Fargo analyst Elyse Greenspan maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Overweight and raises the price target from $334 to $340.

Wells Fargo Maintains Overweight on Willis Towers Watson, Raises Price Target to $340

WIIM

Willis Towers Watson shares are trading higher after the company reported better-than-expected Q3 financial results.

Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) affirms FY2024 Adj EPS guidance from $16.00-17.00 to $16.00-17.00 vs $16.50 analyst estimate..

Guidance

Willis Towers Watson Affirms FY2024 Adj EPS Guidance from $16.00-17.00 to $16.00-17.00 vs $16.50 Est ;Revenue of $9.9B vs Est. 9.92B

Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) reported quarterly earnings of $2.93 per share which beat the analyst consensus estimate of $2.73 by 7.33 percent. The company reported quarterly sales of $2.289 billion which beat the analyst consensus estimate of $2.287 billion by 0.09 percent. This is a 5.68 percent increase over sales of $2.166 billion the same period last year.

Earnings Beats

Willis Towers Watson Q3 2024 Adj. EPS $2.93 Beats $2.73 Estimate, Sales $2.289B Beat $2.287B Estimate

WTW Expands Japan Operations With New Corporate Insurance Brokerage

In the current market session, Willis Towers Watson Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) stock price is at $290.51, after a 0.42% drop. However, over the past month, the company's stock spiked by 0.08%, and in the past year, by 26.86%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1729696525_0.png" alt="Past Year Chart" />

<h3>Willis Towers Watson P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Willis Towers Watson has a lower P/E than the aggregate P/E of 56.04 of the Insurance industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1729696525_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: Willis Towers Watson

Jefferies analyst Yaron Kinar maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Hold and raises the price target from $295 to $314.

Jefferies Maintains Hold on Willis Towers Watson, Raises Price Target to $314

Allstate, Aon, Willis Towers Watson upgraded at Evercore

Piper Sandler analyst Paul Newsome maintained a Buy rating on Willis Towers Watson (WTW – Research Report) today and set a price target of $369.00....

Piper Sandler Remains a Buy on Willis Towers Watson (WTW)

Keefe Bruyette raised the firm's price target on WTW (WTW) to $387 from $378 and keeps an Outperform rating on the shares as part of a Q4 earnings ...

WTW price target raised to $387 from $378 at Keefe Bruyette

Dividend Champion, Contender, And Challenger Highlights: Week Of January 12

Insurers gain Wall Street's vote of confidence, with caveats

Heartland Mid Cap Value Fund Q4 2024 Commentary

Wells Fargo lowered the firm's price target on WTW (WTW) to $345 from $380 and keeps an Overweight rating on the shares. Discussing the insurance i...

WTW price target lowered to $345 from $380 at Wells Fargo

Willis Towers Watson: The Bull Case Remains Intact

Polen International Growth Portfolio Q4 2024 Commentary

Morgan Stanley analyst Bob Huang maintained a Hold rating on Willis Towers Watson (WTW – Research Report) today and set a price target of $320.00. ...

Morgan Stanley Sticks to Its Hold Rating for Willis Towers Watson (WTW)

ABBV

ALRS

APOG

BANF

BCPC

CHCO

CINF

CSLLY

CTRE

CUBE

EHTH

EPRT

EVVTY

FCPT

FFMR

FITB

FMAO

FNLC

FULT

FUNC

GLOB

GWRS

IBCP

IIPR

INTU

INVH

KINS

KMPR

LECO

LVMHF

LVMUY

MDLZ

MELI

MGRC

MNDY

MPWR

NDSN

NWFL

PCCE

PCEM

PCGG

PCIG

PPRUF

PPRUY

RBCAA

REXR

RGCO

RGLD

ROOT

RPRX

SBGSF

SBGSY

SGGEF

SGPYY

SHOP

SPOT

STAG

TFII

THFF

TMNSF

TMSNY

TOWN

WDFC

YORW

Press Releases

WTW Outlines Growth and Value Creation Strategy at 2024 Investor Day

Vessels, undersea cables, and offshore oil installations increasingly becoming "gray zone" targets

Dividends

WTW Announces Regular Quarterly Dividend

US companies refine their approach to ESG metrics in executive pay programs, WTW study finds

US salary budgets expected to remain the same in 2025

Contracts

WTW Completes Sale of TRANZACT

Despite strong equity markets, financial health of largest US corporate pension plans showed modest improvement in 2024

WTW to Announce Fourth Quarter and Full Year Earnings on February 4, 2025

Management

WTW announces Hugo Wegbrans as Head of Corporate Risk and Broking Europe and Simon Delchar as Global Head of Placement

WTW launches IMI Plus for clients in the United States

Abacus Life

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Waterdrop

Comments

Willis Towers Watson

뉴스

에 대한 최신 뉴스 Willis Towers Watson (NASDAQ:WTW) 주식

목요일, 7월 11, 2024

월요일, 5월 06, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌